CD4 and multiple sclerosis: Upon knockout of Kdm6a in a classic mouse model of multiple sclerosis (CD4+ T cell–mediated experimental autoimmune encephalomyelitis), reduced inflammation and a reduction of spinal cord damage to neuronal axons were observed compared with wild-type counterparts [262].